Motzer, R J, Russo, P, Haas, N, Doehn, C, Donskov, F, Gross-Goupil, M, Varlamov, S, Kopyltsov, E, Lee, J L, Lim, H Y, Melichar, B, Zemanova, M, Rini, B, Choueiri, T K, Wood, L, Reaume, M N, Stenzl, A, Chowdhury, S, McDermott, R, Michael, A, Izquierdo, M, Aimone, P, Zhang, H & Sternberg, C N 2021, ' Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma : Final Overall Survival Analysis of the Phase 3 PROTECT Trial ', European Urology, vol. 79, no. 3, pp. 334-338 . https://doi.org/10.1016/j.eururo.2020.12.029
Motzer, R J, Haas, N B, Donskov, F, Gross-Goupil, M, Varlamov, S, Kopyltsov, E, Lee, J L, Melichar, B, Rini, B I, Choueiri, T K, Zemanova, M, Wood, L A, Reaume, M N, Stenzl, A, Chowdhury, S, Lim, H Y, McDermott, R, Michael, A, Bao, W, Carrasco-Alfonso, M J, Aimone, P, Voi, M, Doehn, C, Russo, P, Sternberg, C N & PROTECT investigators 2017, ' Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma ', Journal of Clinical Oncology, vol. 35, no. 35, pp. 3916-3923 . https://doi.org/10.1200/JCO.2017.73.5324